Ameriprise
FOMX

Ameriprise’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Ameriprise’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-60,804
Closed -$202K – 3789
2019
Q4 		$202K Buy
60,804
+750
+1% +$2.38K ﹤0.01% 3577
2019
Q3 		$183K Buy
+60,054
New +$169K ﹤0.01% 3574

Ameriprise's FOMX Position: Q1 2020 in Review

Ameriprise sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 60,804 shares — an estimated $202K sold.

Ameriprise first reported a position in FOMX in Q3 2019 and held it in 2 quarters. The position peaked at $202K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • Ameriprise reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Ameriprise sold 60,804 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $202K.
  • Ameriprise first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2019 and held it in 2 quarters.
  • Ameriprise's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $202K in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Ameriprise's 13F filing for Q1 2020, filed 15 May 2020.